Redcare Pharmacy NV
XETRA:RDC

Watchlist Manager
Redcare Pharmacy NV Logo
Redcare Pharmacy NV
XETRA:RDC
Watchlist
Price: 64.35 EUR 1.42% Market Closed
Market Cap: 1.3B EUR
Section:
 

Relative Value

The Relative Value of one RDC stock under the Base Case scenario is 162.01 EUR. Compared to the current market price of 64.35 EUR, Redcare Pharmacy NV is Undervalued by 60%.

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

RDC Relative Value
Base Case
162.01 EUR
Undervaluation 60%
Relative Value
Price
Worst Case
Base Case
Best Case

Valuation Multiples

0.5
P/S
P/S
Price to Sales
0.5
vs History
98
vs Industry
25
Median 3Y
1.2
Median 5Y
1.3
Industry
0.6
Forward
0.4
More Details
Negative
P/E
P/E
Price to Earnings
N/A
vs History
vs Industry
Median 3Y
-53.7
Median 5Y
-55
Industry
16.8
Forward
-67.6
More Details
39.9
P/OCF
P/OCF
Price to OCF
39.9
vs History
79
vs Industry
2
Median 3Y
53.2
Median 5Y
66.8
Industry
8.5
More Details
23.4
P/FCFE
P/FCFE
Price to FCFE
23.4
vs History
12
vs Industry
1
Median 3Y
-58.7
Median 5Y
-23.5
Industry
17.5
More Details
2.6
P/B
P/B
Price to Book Value
2.6
vs History
90
vs Industry
11
Median 3Y
4.6
Median 5Y
4.9
Industry
1.7
More Details
0.5
EV/S
EV/S
Enterprise Value to Sales
0.5
vs History
98
vs Industry
28
Median 3Y
1.2
Median 5Y
1.3
Industry
0.7
Forward
0.4
More Details
2.1
EV/GP
EV/GP
Enterprise Value to Gross Profit
2.1
vs History
98
vs Industry
21
Median 3Y
4.8
Median 5Y
5.2
Industry
2.3
More Details
37
EV/EBITDA
EV/EBITDA
Enterprise Value to EBITDA
37
vs History
69
vs Industry
2
Median 3Y
54
Median 5Y
55.2
Industry
8.5
Forward
21
More Details
Negative
EV/EBIT
EV/EBIT
Enterprise Value to EBIT
N/A
vs History
vs Industry
Median 3Y
-66.1
Median 5Y
-70.5
Industry
13.1
Forward
-124.8
More Details
41.1
EV/OCF
EV/OCF
Enterprise Value to OCF
41.1
vs History
79
vs Industry
2
Median 3Y
53.3
Median 5Y
67.2
Industry
10.1
More Details
Negative
EV/FCFF
EV/FCFF
Enterprise Value to FCFF
N/A
vs History
vs Industry
3
Median 3Y
-125
Median 5Y
-80.1
Industry
14.2
More Details
1.9
EV/IC
EV/IC
Enterprise Value to IC
1.9
vs History
95
vs Industry
9
Median 3Y
3.7
Median 5Y
4
Industry
1.1
More Details

Multiples Across Competitors

RDC Competitors Multiples
Redcare Pharmacy NV Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
All Countries
All Countries
Close
Market Cap P/S P/E EV/EBITDA EV/EBIT
NL
Redcare Pharmacy NV
XETRA:RDC
1.3B EUR 0.5 -37.2 37 -41.4
ZA
Clicks Group Ltd
JSE:CLS
83.1B Zac 0 0 0 0
ZA
Dis-Chem Pharmacies Ltd
JSE:DCP
30B Zac 0 0 0 0
US
Walgreens Boots Alliance Inc
NASDAQ:WBA
10.4B USD 0.1 -1.6 3 5.1
JP
Tsuruha Holdings Inc
TSE:3391
1.3T JPY 1.1 44.5 15.6 23.2
BR
Raia Drogasil SA
BOVESPA:RADL3
39.8B BRL 1 32.6 10.7 19.5
JP
MatsukiyoCocokara & Co
TSE:3088
1.1T JPY 1 20.1 9.5 12.1
SA
Al Nahdi Medical Company SCJSC
SAU:4164
16.8B SAR 1.7 20.7 10.4 19.2
JP
Welcia Holdings Co Ltd
TSE:3141
657.7B JPY 0.5 34.3 9.1 15.3
JP
Sugi Holdings Co Ltd
TSE:7649
660.7B JPY 0.7 16 9 12.9
JP
Cosmos Pharmaceutical Corp
TSE:3349
634.9B JPY 0.6 20.5 9.9 15.4
EV/EBIT Multiple
EBIT Growth EV/EBIT to Growth
NL
Redcare Pharmacy NV
XETRA:RDC
Average EV/EBIT: 15.3
Negative Multiple: -41.4 		N/A N/A
ZA
C
Clicks Group Ltd
JSE:CLS
Not Available
11%
N/A
ZA
D
Dis-Chem Pharmacies Ltd
JSE:DCP
Not Available
10%
N/A
US
Walgreens Boots Alliance Inc
NASDAQ:WBA
5.1
-5%
N/A
JP
Tsuruha Holdings Inc
TSE:3391
23.2
N/A N/A
BR
Raia Drogasil SA
BOVESPA:RADL3
19.5
15%
1.3
JP
MatsukiyoCocokara & Co
TSE:3088
12.1
N/A N/A
SA
Al Nahdi Medical Company SCJSC
SAU:4164
19.2
8%
2.4
JP
Welcia Holdings Co Ltd
TSE:3141
15.3
N/A N/A
JP
S
Sugi Holdings Co Ltd
TSE:7649
12.9
N/A N/A
JP
Cosmos Pharmaceutical Corp
TSE:3349
15.4
N/A N/A

See Also

Summary
RDC intrinsic value, competitors valuation, and company profile.
DCF Valuation
RDC stock valuation using Discount Cash Flow valuation method.
Relative Valuation
RDC stock valuation using valuation multiples.
Wall Street Estimates
RDC price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
RDC stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
Back to Top
ALPHA SPREAD
Follow us
Join more than 303,900+ value investors using Alpha Spread
Create Free Account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks Wide Economic Moat Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2025 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.